Allergopharma Subcutaneous Allergen Immunotherapy

Allergopharma Subcutaneous Allergen Immunotherapy (SCIT) refers to a range of therapeutic products developed by Allergopharma (a subsidiary of Dermapharm) for the treatment of IgE-mediated allergic diseases. These products consist of specific allergen extracts, such as grass pollen, house dust mites, and birch pollen, which are adsorbed to aluminum hydroxide to create a depot effect. The treatment involves the repeated subcutaneous administration of these extracts to gradually induce immune tolerance and desensitize the patient's immune system. The product line includes **Novo-Helisen Depot**, which contains unmodified allergen extracts, and **Allergovit**, which consists of modified allergoids (hypoallergenic, high-dose preparations). These therapies are primarily indicated for allergic rhinitis, seasonal allergies, house dust mite allergy, and allergic asthma, aiming to modify the underlying allergic immune response rather than just treating symptoms.

Brand names

Novo-Helisen DepotAllergovit

Other names

subcutaneous allergen immunotherapySCITallergen extractsallergoidssubcutaneous preparations